Almac Group Launches Almac Adapt
Almac Clinical Services, part of the Almac Group, has today announced the launch of Almac Adapt - a Just in Time Manufacturing (JTM) solution.
The Almac Adapt solution offers the timely generation and delivery of kits to sites and patients worldwide. By shifting the focus from what we do to why we do it, Almac Adapt embodies this understanding in a patient-centric culture by translating itself into an actionable and proactive manufacturing, packaging, labelling and distribution solution.
This solution manipulates the global supply chain and bridges the gap between supply and demand - optimizing on-time delivery for patients, inventory flexibility for sites whilst achieving key time-based milestones for the sponsor.
To find out more about this service, please visit www.almacgroup.com
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
